Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 32 studies | 45% ± 18% | |
classical monocyte | 25 studies | 44% ± 15% | |
non-classical monocyte | 22 studies | 49% ± 17% | |
monocyte | 19 studies | 37% ± 15% | |
conventional dendritic cell | 17 studies | 37% ± 16% | |
fibroblast | 17 studies | 27% ± 12% | |
dendritic cell | 15 studies | 44% ± 18% | |
memory B cell | 14 studies | 21% ± 4% | |
plasmacytoid dendritic cell | 14 studies | 32% ± 11% | |
myeloid cell | 13 studies | 40% ± 20% | |
naive B cell | 11 studies | 20% ± 3% | |
astrocyte | 10 studies | 33% ± 17% | |
pericyte | 10 studies | 24% ± 10% | |
B cell | 9 studies | 21% ± 4% | |
alveolar macrophage | 8 studies | 51% ± 22% | |
ciliated cell | 8 studies | 31% ± 8% | |
endothelial cell | 8 studies | 30% ± 11% | |
basal cell | 7 studies | 30% ± 13% | |
connective tissue cell | 7 studies | 28% ± 8% | |
neutrophil | 6 studies | 28% ± 8% | |
abnormal cell | 6 studies | 31% ± 8% | |
epithelial cell | 6 studies | 45% ± 20% | |
smooth muscle cell | 5 studies | 24% ± 8% | |
intermediate monocyte | 5 studies | 58% ± 12% | |
regulatory T cell | 5 studies | 18% ± 3% | |
erythrocyte | 4 studies | 23% ± 3% | |
mononuclear phagocyte | 4 studies | 34% ± 12% | |
neuron | 4 studies | 45% ± 14% | |
glutamatergic neuron | 4 studies | 26% ± 15% | |
retinal ganglion cell | 4 studies | 56% ± 27% | |
retinal cone cell | 4 studies | 51% ± 23% | |
CD16-negative, CD56-bright natural killer cell, human | 4 studies | 19% ± 2% | |
myofibroblast cell | 4 studies | 30% ± 7% | |
type II pneumocyte | 4 studies | 23% ± 8% | |
vein endothelial cell | 4 studies | 23% ± 7% | |
retinal rod cell | 4 studies | 31% ± 12% | |
adipocyte | 4 studies | 25% ± 11% | |
plasmablast | 3 studies | 27% ± 7% | |
pancreatic A cell | 3 studies | 34% ± 10% | |
retinal bipolar neuron | 3 studies | 37% ± 13% | |
precursor B cell | 3 studies | 31% ± 6% | |
plasma cell | 3 studies | 27% ± 4% | |
capillary endothelial cell | 3 studies | 29% ± 13% | |
endothelial cell of lymphatic vessel | 3 studies | 28% ± 9% | |
immature B cell | 3 studies | 22% ± 3% | |
Mueller cell | 3 studies | 23% ± 8% | |
inflammatory macrophage | 3 studies | 31% ± 14% | |
hematopoietic stem cell | 3 studies | 24% ± 2% | |
enteroendocrine cell | 3 studies | 26% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 12 studies | 28% ± 10% | |
peripheral blood | 11 studies | 24% ± 5% | |
brain | 5 studies | 29% ± 12% | |
eye | 5 studies | 30% ± 12% | |
pancreas | 3 studies | 28% ± 7% | |
kidney | 3 studies | 22% ± 4% | |
placenta | 3 studies | 23% ± 2% | |
intestine | 3 studies | 23% ± 9% | |
liver | 3 studies | 16% ± 0% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 16029.73 | 226 / 226 | 100% | 477.12 | 406 / 406 |
ovary | 100% | 10347.34 | 180 / 180 | 100% | 538.69 | 430 / 430 |
skin | 100% | 11220.89 | 1809 / 1809 | 100% | 507.92 | 472 / 472 |
esophagus | 100% | 9289.39 | 1444 / 1445 | 100% | 262.03 | 183 / 183 |
thymus | 100% | 14161.39 | 653 / 653 | 100% | 391.92 | 604 / 605 |
brain | 100% | 14441.15 | 2635 / 2642 | 100% | 461.16 | 705 / 705 |
prostate | 100% | 12632.07 | 245 / 245 | 99% | 406.83 | 498 / 502 |
kidney | 100% | 12381.54 | 89 / 89 | 99% | 314.20 | 893 / 901 |
breast | 100% | 16995.07 | 459 / 459 | 99% | 497.23 | 1106 / 1118 |
intestine | 100% | 9113.36 | 964 / 966 | 99% | 300.63 | 522 / 527 |
lung | 100% | 16988.92 | 578 / 578 | 99% | 285.33 | 1140 / 1155 |
adrenal gland | 100% | 15079.97 | 258 / 258 | 97% | 230.55 | 224 / 230 |
uterus | 100% | 10665.12 | 170 / 170 | 97% | 225.69 | 444 / 459 |
bladder | 100% | 11621.95 | 21 / 21 | 96% | 280.82 | 486 / 504 |
stomach | 96% | 6161.35 | 344 / 359 | 99% | 291.46 | 284 / 286 |
pancreas | 88% | 3621.01 | 289 / 328 | 99% | 228.15 | 176 / 178 |
adipose | 100% | 18525.58 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 802.88 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 390.34 | 29 / 29 |
peripheral blood | 100% | 31331.35 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 21261.87 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 205.05 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 202.27 | 1 / 1 |
blood vessel | 100% | 7762.12 | 1332 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 6001.88 | 792 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 6471.84 | 824 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902236 | Biological process | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
GO_0032469 | Biological process | endoplasmic reticulum calcium ion homeostasis |
GO_2001234 | Biological process | negative regulation of apoptotic signaling pathway |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0016020 | Cellular component | membrane |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0005515 | Molecular function | protein binding |
Gene name | GRINA |
Protein name | Glutamate ionotropic receptor NMDA type subunit associated protein 1 Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit) (Putative MAPK-activating protein PM02) (Transmembrane BAX inhibitor motif-containing protein 3) |
Synonyms | TMBIM3 NMDARA1 LFG1 |
Description | FUNCTION: Potential apoptotic regulator. |
Accessions | E9PPG3 Q7Z429 H0YEI4 H0YC98 H0YCP9 ENST00000527194.5 ENST00000395068.9 ENST00000313269.5 ENST00000529301.5 ENST00000530898.1 ENST00000533044.5 ENST00000534791.5 E9PQF8 |